1355592-91-4

Upstream product

• 1355592-60-7 methyl 3-(tert-butoxycarbonylamino)tetralin-6-carboxylate 
• 145822-46-4 7-[(tert-butoxycarbonyl)amino]-5,6,7,8-tetrahydronaphthalen-2-yltrifluoromethanesulfonate 
• 83343-23-1 N-benzyl-7-methoxy-1,2,3,4-tetrahydronaphthalen-2-amine 
• 194785-79-0 7-hydroxy-1,2,3,4-tetrahydro-2-naphthylamine hydrobromide 
• 145919-89-7 tert-butyl (7-hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)carbamate 
• 1355592-51-6 methyl 3-aminotetralin-6-carboxylate hydrochloride 
• 10365-98-7 3-methoxyphenylboronic acid 
• 4133-34-0 7-methoxyl-2-tetralone 
• 4003-89-8 2-amino-7-methoxy-1,2,3,4-tetrahydronaphthalene 

Relevant academic research and scientific papers

SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF

This invention provides compounds of formula (I): wherein R1, R1b, R2a, R2b, R2c, and R2d have values as described in the specification, useful as inhibitors of HDAC6. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of proliferative, inflammatory, infectious, neurological or cardiovascular diseases or disorders.